Patents by Inventor Marc Vidal

Marc Vidal has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10788537
    Abstract: There is described a dissociating module for monitoring an object and managing electric input into and output from the object, the object being a battery or a load. The dissociating module is for use with at least one other dissociating module. The dissociating module comprises: measuring devices for taking measurements of the object; a microcontroller operatively connected to the measuring devices for receiving the measurements of the objects, and for operative connection to a microcontroller of the at least one other dissociating module for receiving information therefrom; and switches, operatively connected to the microcontroller. The microcontroller, based on at least one of the measurements of the object received and the information received from the at least one other dissociating module, controls opening and closing of the switches for controlling electrical current in the dissociating module.
    Type: Grant
    Filed: August 3, 2016
    Date of Patent: September 29, 2020
    Assignee: ID3D Technologies inc.
    Inventor: Marc Vidal
  • Publication number: 20190100534
    Abstract: Cephem and penem compounds having a styrylmethylene moiety at the 3-position in the cephem or penem ring to which a positively charged leaving group is bonded and wherein the leaving group contains a vicinal diol or is bonded to a unsubstituted or substituted catechol. The leaving group can be a positively charge nitrogen leaving group. Cephems include cephalosporins, cephamycins, carbacephems, and oxacephems. Penems include penems, carbapenems and oxapenems. Preferred cephems are cephalosporins. Preferred penems are carbapenems. Compounds exhibit antibiotic activity against Gram-negative bacteria and/or Gram-positive bacteria. Compounds exhibit antibiotic activity against bacteria which exhibit multi-drug resistance. Compounds of the invention exhibit antibiotic activity against bacterial strains which produce extended spectrum beta-lactamases (ESBL), which produce AmpC beta-lactamases or which produce a carbapenemase.
    Type: Application
    Filed: October 4, 2018
    Publication date: April 4, 2019
    Inventors: Larry D. SUTTON, Robert ZAMBONI, Patrick BUREAU, Avid HASSANPOUR, Laura MAMANI LAPARRA, Marc VIDAL, Simon WOO, Nancy ZHOU, Richard M. KEENAN
  • Publication number: 20180231614
    Abstract: There is described a dissociating module for monitoring an object and managing electric input into and output from the object, the object being a battery or a load. The dissociating module is for use with at least one other dissociating module. The dissociating module comprises: measuring devices for taking measurements of the object; a microcontroller operatively connected to the measuring devices for receiving the measurements of the objects, and for operative connection to a microcontroller of the at least one other dissociating module for receiving information therefrom; and switches, operatively connected to the microcontroller. The microcontroller, based on at least one of the measurements of the object received and the information received from the at least one other dissociating module, controls opening and closing of the switches for controlling electrical current in the dissociating module.
    Type: Application
    Filed: August 3, 2016
    Publication date: August 16, 2018
    Inventor: Marc VIDAL
  • Patent number: 7601533
    Abstract: Disclosed are methods for identifying molecular interactions (e.g., protein/protein, protein/DNA, protein/RNA, or RNA/RNA interactions). All of the methods within the invention employ counterselection and at least two hybrid molecules. Molecules which interact reconstitute a transcription factor and direct expression of a reporter gene, the expression of which is then assayed. Also disclosed are genetic constructs which are useful in practicing the methods of the invention.
    Type: Grant
    Filed: February 13, 2006
    Date of Patent: October 13, 2009
    Assignees: The General Hospital Corporation, The John Hopkins University
    Inventors: Marc Vidal, Jef Boeke, Ed Harlow
  • Publication number: 20060286600
    Abstract: The invention relates to a new high throughput yeast one-hybrid screening system.
    Type: Application
    Filed: June 30, 2004
    Publication date: December 21, 2006
    Inventors: Albertha Walhout, Marc Vidal, Bart Deplancke
  • Publication number: 20060223089
    Abstract: Disclosed are methods for identifying molecular interactions (e.g., protein/protein, protein/DNA, protein/RNA, or RNA/RNA interactions). All of the methods within the invention employ counterselection and at least two hybrid molecules. Molecules which interact reconstitute a transcription factor and direct expression of a reporter gene, the expression of which is then assayed. Also disclosed are genetic constructs which are useful in practicing the methods of the invention.
    Type: Application
    Filed: February 13, 2006
    Publication date: October 5, 2006
    Applicants: The Johns Hopkins University, The General Hospital Corporation
    Inventors: Marc Vidal, Jef Boeke, Ed Harlow
  • Patent number: 7033768
    Abstract: Disclosed are methods for identifying molecular interactions (e.g., protein/protein, protein/DNA, protein/RNA, or RNA/RNA interactions). All of the methods within the invention employ counterselection and at least two hybrid molecules. Molecules which interact reconstitute a transcription factor and direct expression of a reporter gene, the expression of which is then assayed. Also disclosed are genetic constructs which are useful in practicing the methods of the invention.
    Type: Grant
    Filed: December 21, 2001
    Date of Patent: April 25, 2006
    Assignees: The General Hospital Corporation, The John Hopkins University
    Inventors: Marc Vidal, Jef D. Boeke, Ed Harlow
  • Publication number: 20050053913
    Abstract: Disclosed are methods for identifying molecular interactions (e.g., protein/protein, protein/DNA, protein/RNA, or RNA/RNA interactions). All of the methods within the invention employ counterselection and at least two hybrid molecules. Molecules which interact reconstitute a transcription factor and direct expression of a reporter gene, the expression of which is then assayed. Also disclosed are genetic constructs which are useful in practicing the methods of the invention.
    Type: Application
    Filed: August 18, 2004
    Publication date: March 10, 2005
    Inventors: Marc Vidal, Jef Boeke, Ed Harlow
  • Publication number: 20030124538
    Abstract: Disclosed are methods for identifying molecular interactions (e.g., protein/protein, protein/DNA, protein/RNA, or RNA/RNA interactions). All of the methods within the invention employ counterselection and at least two hybrid molecules. Molecules which interact reconstitute a transcription factor and direct expression of a reporter gene, the expression of which is then assayed. Also disclosed are genetic constructs which are useful in practicing the methods of the invention.
    Type: Application
    Filed: December 21, 2001
    Publication date: July 3, 2003
    Applicant: The John Hopkins University, a Maryland corporation
    Inventors: Marc Vidal, Jef Boeke, Ed Harlow
  • Publication number: 20030068612
    Abstract: Disclosed are methods for identifying molecular interactions (e.g., protein/protein, protein/DNA, protein/RNA, or RNA/RNA interactions). All of the methods within the invention employ counterselection and at least two hybrid molecules. Molecules which interact reconstitute a transcription factor and direct expression of a reporter gene, the expression of which is then assayed. Also disclosed are genetic constructs which are useful in practicing the methods of the invention.
    Type: Application
    Filed: June 26, 2002
    Publication date: April 10, 2003
    Applicant: The General Hospital Corporation, a Massachusetts corporation
    Inventors: Marc Vidal, Jef D. Boeke, Ed Harlow
  • Publication number: 20020197627
    Abstract: Disclosed are methods for identifying molecular interactions (e.g., protein/protein, protein/DNA, protein/RNA, or RNA/RNA interactions). All of the methods within the invention employ counterselection and at least two hybrid molecules. Molecules which interact reconstitute a transcription factor and direct expression of a reporter gene, the expression of which is then assayed. Also disclosed are genetic constructs which are useful in practicing the methods of the invention.
    Type: Application
    Filed: March 27, 2002
    Publication date: December 26, 2002
    Applicant: The General Hospital Corporation, a Massachusetts corporation
    Inventors: Marc Vidal, Jef D. Boeke, Ed Harlow
  • Patent number: 5965368
    Abstract: Disclosed are methods for identifying molecular interactions (e.g., protein/protein, protein/DNA, protein/RNA, or RNA/RNA interactions). All of the methods within the invention employ counterselection and at least two hybrid molecules. Molecules which interact reconstitute a transcription factor and direct expression of a reporter gene, the expression of which is then assayed. Also disclosed are genetic constructs which are useful in practicing the methods of the invention.
    Type: Grant
    Filed: October 24, 1997
    Date of Patent: October 12, 1999
    Assignees: The General Hospital Corporation, The Johns Hopkins University
    Inventors: Marc Vidal, Jef D. Boeke, Ed Harlow
  • Patent number: 5955280
    Abstract: Disclosed are methods for identifying molecular interactions (e.g., protein/protein, protein/DNA, protein/RNA, or RNA/RNA interactions). All of the methods within the invention employ counterselection and at least two hybrid molecules. Molecules which interact reconstitute a transcription factor and direct expression of a reporter gene, the expression of which is then assayed. Also disclosed are genetic constructs which are useful in practicing the methods of the invention.
    Type: Grant
    Filed: September 4, 1997
    Date of Patent: September 21, 1999
    Assignees: The General Hospital Corporation, The Johns Hopkins University
    Inventors: Marc Vidal, Jef D. Boeke, Ed Harlow